| Title |
Ten years of biosimilar recombinant human growth hormone in Europe
|
|---|---|
| Published in |
Drug Design, Development and Therapy, May 2017
|
| DOI | 10.2147/dddt.s130317 |
| Pubmed ID | |
| Authors |
Paul Saenger |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 31 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 29% |
| Student > Bachelor | 3 | 10% |
| Other | 2 | 6% |
| Researcher | 2 | 6% |
| Student > Doctoral Student | 1 | 3% |
| Other | 5 | 16% |
| Unknown | 9 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 7 | 23% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 19% |
| Chemistry | 3 | 10% |
| Medicine and Dentistry | 2 | 6% |
| Social Sciences | 1 | 3% |
| Other | 3 | 10% |
| Unknown | 9 | 29% |